H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Census population 681,054. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Oklahoma City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Oklahoma City storefront.
Joint Preservation Therapy Solutions in Oklahoma City, OK for clinics & physicians. Joint preservation the… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Census city-proper population is 681,054. If you are adding joint preservation therapy, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Joint Preservation Therapy Solutions notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Adult obesity in Oklahoma City is 38.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 25.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, TX. Oklahoma State Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Oklahoma City warehouse or a five-star local review. What you get is joint preservation therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JH, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.6% of adults — 0.6 points above the U.S. 12% figure. Obesity is 38.3%; arthritis is 25.8%. That is place-level BRFSS modeling, not a clinic census and not a Oklahoma City trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Oklahoma.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Oklahoma. There is no Oklahoma City storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
If you operate in Oklahoma and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Oklahoma City tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Oklahoma City, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Oklahoma City is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Oklahoma City — 0.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Oklahoma City. Useful for joint-program math; still needs a diagnosis and privileging.
No Oklahoma City storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.